[Isolation and applications of transformation suppressor genes].
A common strategy to identify tumor suppressor genes has been positional cloning, taking advantages of chromosomal abnormalities, linkage to polymorphic markers, etc. We have been taking another approach, based on shotgun cloning with cDNA-expression library, to isolate genes suppressing an aspect of transformed phenotypes. Genes identified in such an artificial system, however, require subsequent validation for their clinical relevance through independent approaches, such as finding mutations and altered expression in human cancers. Whether the parental genes act as oncogenes or tumor suppressors needs to be deduced from available annotations and/or new experimental data. Once validated, such genes, being isolated by virtue of their biological activities, are likely to be useful in developing new strategies for tumor prognosis, tumor stratification, and drug discovery.
Makoto
M
Noda
Tomoko
T
Matsuzaki
Yoko
Y
Yoshida
Hitoshi
H
Kitayama
D000818:Animals; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002471:Cell Transformation, Neoplastic / Q000235:genetics* / Q000473:pathology; D003001:Cloning, Molecular / Q000379:methods; D055808:Drug Discovery; D058851:GPI-Linked Proteins; D015723:Gene Library; D016147:Genes, Tumor Suppressor; D006801:Humans; D037181:Lectins, C-Type; D051379:Mice; D009154:Mutation; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D000073718:Pancreatitis-Associated Proteins
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D058851:GPI-Linked Proteins; D037181:Lectins, C-Type; D000073718:Pancreatitis-Associated Proteins; C115460:RECK protein, human; C000612141:REG3A protein, human